Jane M. Green
Präsident bei JMG Communications LLC
Profil
Dr. Jane M.
Green is Vice President at Cross Current Research LLC.
Prior to joining Cross Current Research, Dr. Green has worked in-house as the senior communications executive and member of the executive management team in companies with pioneering and controversial technology platforms such as anti-sense (Isis Pharmaceuticals), microfluidics (Caliper Technologies), kinase-based drug discovery (Exelixis) toll-like receptor immune modulators (Dynavax), and Hsp90 inhibitors (Kosan).
Both in-house and as a communication consultant, she has provided intelligent, rigorous and effective communication on behalf of companies undergoing transformational events including clinical, regulatory or commercial successes or setbacks, product launches and withdrawals, financing in optimal as well as distressed circumstances, mergers, acquisitions and major corporate transactions, securities and patent litigation, management turnover; corporate restructuring and corporate re-branding and identity management.
Jane is well-known and respected throughout the life sciences industry and within the healthcare investing and equity research communities.
Dr. Green received her undergraduate degree from the University of Pennsylvania and a doctorate degree from SUNY Buffalo.
Aktive Positionen von Jane M. Green
Unternehmen | Position | Beginn |
---|---|---|
JMG Communications LLC | Präsident | - |
Ehemalige bekannte Positionen von Jane M. Green
Unternehmen | Position | Ende |
---|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Investor Relations Kontakt | 01.06.2008 |
EXELIXIS, INC. | Public Communications Contact | - |
Cross Current Research LLC
Cross Current Research LLC Investment ManagersFinance Founded in 2009 by Dr. Alex To, Cross Current Research LLC is an independent research firm located in Skillman, New Jersey. The firm offers comprehensive fundamental industry and company-specific research, as well as technical analysis of stocks and markets. They cover the healthcare, technology and financial services sectors. Cross Current Research offers services to institutional investors. | Institutionelle Verkäufe | 11.08.2011 |
DYNAVAX TECHNOLOGIES CORPORATION | Public Communications Contact | - |
Ausbildung von Jane M. Green
University of Pennsylvania | Undergraduate Degree |
State University of New York at Buffalo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EXELIXIS, INC. | Health Technology |
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Cross Current Research LLC
Cross Current Research LLC Investment ManagersFinance Founded in 2009 by Dr. Alex To, Cross Current Research LLC is an independent research firm located in Skillman, New Jersey. The firm offers comprehensive fundamental industry and company-specific research, as well as technical analysis of stocks and markets. They cover the healthcare, technology and financial services sectors. Cross Current Research offers services to institutional investors. | Finance |
JMG Communications LLC |